Meet ProJect Pharmaceutics at CPhI 2025 Read More » October 17, 2025 Today, we proudly celebrate our 15th company anniversary! 🎉 Read More » September 17, 2025 ProJect Pharmaceutics announces a new partnership with Afinum to support the next phase of its growth. Read More » September 11, 2025 Formulation Scientist (m/w) Read More » April 23, 2025 Meet ProJect Pharmaceutics at 16th World ADC London March 2026 Read More » March 14, 2025 Meet ProJect Pharmaceutics at 15th World ADC London 2025 Read More » December 2, 2024 ProJect Pharmaceutics’ announces extension of service offering: In-use stability studies Read More » May 6, 2024 ProJect Pharmaceutics receives CIR application renewal (Research Tax Credit) for the benefit of its French customers towards 2025 Read More » January 15, 2024 ProJect Pharmaceutics was granted a US patent on a novel liquid formulation of Bendamustine Read More » October 25, 2023 ProJect Pharmaceutics’ announces new service offering: Excipient quantification Read More » June 5, 2023 Follow us on LinkedIn Read More » November 18, 2022 ProJect Pharmaceutics’ announces new service offering: Determination of the molar protein extinction coefficient according to ICHQ6 Read More » May 10, 2022 Page1 Page2 Page3
ProJect Pharmaceutics announces a new partnership with Afinum to support the next phase of its growth. Read More » September 11, 2025
ProJect Pharmaceutics’ announces extension of service offering: In-use stability studies Read More » May 6, 2024
ProJect Pharmaceutics receives CIR application renewal (Research Tax Credit) for the benefit of its French customers towards 2025 Read More » January 15, 2024
ProJect Pharmaceutics was granted a US patent on a novel liquid formulation of Bendamustine Read More » October 25, 2023
ProJect Pharmaceutics’ announces new service offering: Excipient quantification Read More » June 5, 2023
ProJect Pharmaceutics’ announces new service offering: Determination of the molar protein extinction coefficient according to ICHQ6 Read More » May 10, 2022
